For more information or confidential assistance
Call 516.741.5600

FDA Updates Warning About Invokana Bone Risks

The FDA has strengthened warnings that diabetes drug Invokana is related to an increased risk of bone fractures and a significantly greater loss of bone density than a placebo. The move comes as a result of the findings of clinical trials involving Invokana (canagliflozin) and 714 elderly subjects... Read More